Haraldsson, Erik http://orcid.org/0000-0002-0752-2253
Halimi, Asif
Rangelova, Elena
Valente, Roberto
Löhr, J. Matthias
Arnelo, Urban
Funding for this research was provided by:
Research fund at Skaraborg Hospital (VGSKAS-901291)
Stockholms Läns Landsting (SLL: ALF 20170480)
Cancerfonden (19 0513 Fk 01 H)
Article History
Received: 13 January 2021
Accepted: 17 April 2021
First Online: 3 May 2021
Declarations
:
: Dr. Urban Arnelo has been engaged as a consultant for Ambu A/S, Boston Scientific Inc, and Medtronic and receives funding from the Stockholm County Council, the Karolinska Institute (SLL: ALF 20170480), and the Swedish Cancer Society (Cancerfonden, 19 0513 Fk 01 H). Dr. Erik Haraldsson has received funding from the Research Fund at Skaraborg Hospital, Skövde, Sweden (VGSKAS-901291) during the conduct of the study. Drs. Asif Halimi, Elena Rangelova, Roberto Valente, J-Matthias Löhr have no conflicts of interest or financial ties to disclose.